Cite
HARVARD Citation
Wu, J. et al. (2022). Time to onset of cannabidiol treatment effect and resolution of adverse events in tuberous sclerosis complex: Post hoc analysis of randomized controlled phase 3 trial GWPCARE6. Epilepsia. 63 (5), pp. 1189-1199. [Online].